Frajese et al. (2006)
The aim of this article is to critically review the available evidence from the tadalafil clinical research program and give the physician a rational [...]
December 2006
September 2006
RegeneRx Biopharmaceuticals (2006)
This clinical trial studies the effect of Thymosin Beta 4 in alleviating symptoms of Pressure Ulcers. STUDIES & RESEARCH [...]
Ionescu et al. (2006)
This study finds CJC-1295 increased trough and mean GH secretion and IGF-I production with preserved GH pulsatility. The marked enhancement of trough GH levels [...]
Ying, Weihai (2006)
NAD+ and NADH in cellular functions and cell death." Front Biosci 11.1 (2006)
July 2006
Rajfer et al. (2006)
The efficacy and safety of tadalafil, dosed once a day for the treatment of erectile dysfunction, was assessed in a randomized, double-blind, placebo-controlled, parallel-design [...]
March 2006
Teichman et al. (2006)
Subcutaneous administration of CJC-1295 resulted in sustained, dose-dependent increases in GH and IGF-I levels in healthy adults and was safe and relatively well tolerated, [...]
October 2005
LoVerme et al. (2005)
This study outlines the history of PEA, starting with its initial discovery in the 1950s, and discusses the pharmacological properties of this compound, particularly [...]
February 2005
Laferrére et al. (1998)
GHRP-2 is a synthetic agonist of ghrelin, the newly-discovered gut peptide which binds to the growth hormone (GH) secretagogue receptor. Ghrelin has been shown [...]
August 2004
R. A. Rastall (2004)
NAD+ metabolism and its roles in cellular processes during ageing.
February 2004
Diamond et al. (2004)
PT-141, a cyclic heptapeptide melanocortin analog, was evaluated following intranasal administration in healthy male subjects and in Viagra-responsive erectile dysfunction (ED) patients. Erectile response [...]